Syft sees at least $350m pa opportunity in life sciences
Christchurch company is diversifying from semiconductors into pharma and chemicals.
Syft Technologies has already scoped a $350 million per year market opportunity for just one application of its technology in the life sciences space, as it pushes to diversify its revenue stream beyond semiconductor manufacturers.
Christchurch-based Syft, which makes mass spectrometer sensors
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
NZ$399.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Will Mace
Thu, 07 Apr 2022
Thu, 07 Apr 2022
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Syft sees at least $350m pa opportunity in life sciences
Business,
91132